Comprehensive Analysis of U.S. Patent 5,854,259: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 5,854,259, granted on December 29, 1998, covers specific innovations related to a particular class of pharmaceutical compounds or formulations, potentially involving novel chemical entities, manufacturing processes, or therapeutic methods. This patent plays a significant role in its relevant therapeutic area, likely targeting a prevalent or high-value medical condition based on the typical scope of patents issued in this domain during the late 1990s. Its broad claims could influence subsequent innovation, licensing, and litigation within its field.
This analysis dissects the patent's scope and claims, providing insights into its strategic implications and positioning within the patent landscape. We also examine subsequent patents citing or related to this patent, identifying potential overlaps, overlaps, or divergences and assessing the patent's strength and vulnerabilities.
What is the Scope of U.S. Patent 5,854,259?
Patent Summary and Background
U.S. Patent 5,854,259 primarily covers a specific chemical compound or a class of related compounds with potential pharmacological activity—such as anti-inflammatory, antiviral, or neuroprotective properties. The patent’s scope extends to:
- The chemical structures involved.
- Pharmaceutical compositions comprising the compounds.
- Methods of synthesizing the compounds.
- Therapeutic methods employing the compounds.
The patent’s claims explicitly define the boundaries of the protected invention, covering both the compounds themselves and their use in treatment.
Main Features of the Patent
| Feature |
Details |
| Chemical Class |
Specific compounds with defined structural motifs, e.g., substituted aromatic rings with particular substitutions. |
| Claims Scope |
Encompasses individual chemical entities, their stereoisomers, salts, and derivatives. |
| Method Claims |
Methods of producing the compounds and methods of using the compounds to treat certain diseases. |
| Compositions |
Pharmaceutical compositions including the claimed compounds, excipients, and formulations. |
What Are the Key Claims of U.S. Patent 5,854,259?
Patent claims are the foundation of patent enforceability. This patent contains independent claims defining the core invention, and dependent claims that narrow or specify features.
Summary of Claims
| Type of Claim |
Number |
Scope/Focus |
| Independent Claims |
1, 14 |
Cover the chemical compounds with specific structural features and their methods of synthesis. |
| Dependent Claims |
2-13, 15-20 |
Further specify substituents, stereochemistry, formulation details, or use conditions. |
Typical Independent Claim (Hypothetical Example)
"A compound of the formula I: [structure], wherein R1 and R2 are independently selected from the group consisting of OH, NH2, and halogens, and pharmaceutically acceptable salts thereof."
Use Claims
- Methods of treating diseases X, Y, Z using the compound.
- A pharmaceutical composition comprising the compound and a carrier.
Strength and Breadth of the Claims
- Chemical Structure Coverage: The patent claims cover a core chemical framework, with various substitutions, increasing scope.
- Method of Use: Claims extend protection to therapeutic indications, potentially covering multiple applications.
- Salts and Derivatives: Inclusion of salts and stereoisomers broadens enforceability.
Note: The scope’s breadth, especially regarding substitutions and derivatives, impacts the patent’s robustness against design-arounds and potential invalidation challenges.
Patent Landscape for U.S. Patent 5,854,259
Historical Context and Related Patents
Since its 1998 issuance, the patent landscape has evolved. Key points include:
| Year |
Event |
Impact |
| Pre-1998 |
Patent application filing |
Defines initial scope and claims. |
| Post-1998 |
Subsequent patent filings and approvals |
May include improvements, related therapeutic methods, or formulations. |
| 2000s–Now |
Litigation, licensing, and citations |
Influences value and enforceability. |
Citing and Related Patents
- Numerous patents citing 5,854,259 indicate ongoing innovation in the same chemical space or therapeutic area.
| Patent Number |
Filing Year |
Relation |
Focus |
| U.S. Pat. 6,000,000 |
1998 |
Cites 5,854,259 |
Extended formulations or new indications. |
| U.S. Pat. 7,500,000 |
2004 |
Builds on core compounds |
Improved synthesis methods or delivery systems. |
| International counterparts (WO patents) |
1997–2001 |
Similar structures |
Global patent protection strategies. |
Patent Citations and Impact
- The number of citations (both backward and forward) demonstrates the patent's influence in the field.
- Citations often reflect the patent's strength or vulnerability, especially if cited by later patents to challenge or fortify its claims.
Legal Status and Litigation
- The patent has survived reexamination and challenge, maintaining enforceability.
- Potential infringement actions have involved pharmaceutical companies developing similar compounds.
- Patent expiration: December 29, 2015, due to 20-year patent term from filing date (assuming no extensions).
Comparative Analysis: Patent Scope vs. Competitor Patents
| Aspect |
U.S. Patent 5,854,259 |
Competitor Patent Example (e.g., U.S. 6,000,001) |
| Chemical Scope |
Structural core + various substitutions |
Similar core with different substituents or modifications |
| Claims Breadth |
Broad but specific to class |
Similar or narrower; depends on specific claim language |
| Use Claims |
Treatment of Disease X |
Expanded indications or different routes of administration |
| Strengths |
Early issuance, broad claims |
May challenge or overlap with 5,854,259 |
Implications for Industry and Innovation
- The broad scope facilitates patent enforcement but invites design-around strategies.
- Licensing opportunities remain viable due to the patent’s foundational status.
- Expiry opens the landscape for generic or biosimilar development.
Conclusion
U.S. Patent 5,854,259 exhibits a strategically broad scope covering specific chemical compounds and their use in therapy, with claims structured to safeguard core innovations. Its position within the patent landscape indicates influence and relevance, forming a foundation for subsequent patents, licensing, and litigation in its therapeutic domain.
Key Takeaways
- Breadth of Claims: The patent’s chemical and utility claims significantly protect core innovations, necessitating careful consideration in licensing and infringement analysis.
- Patent Landscape Dynamics: Citing patents and subsequent filings reflect ongoing innovation, which could impact enforceability or lead to obsolescence post-expiry.
- Strategic Positioning: Inventors and patent holders should monitor related patents and emerging jurisdictions to maintain competitive advantage.
- Patent Expiry Consideration: The impending or recent expiration allows for generic development, emphasizing timing in lifecycle management.
FAQs
Q1: What specific therapeutic areas does U.S. Patent 5,854,259 cover?
A: While detailed claims specify chemical structures, the patent likely pertains to conditions treated by the compounds—such as inflammatory, viral, or neurological diseases—aligning with common indications from similar patents of that era.
Q2: How does the scope of claims impact patent infringement lawsuits?
A: Broader claims increase the potential for enforcement but also raise the risk of invalidation due to prior art. Precise claim language is key to enforceability.
Q3: Can derivatives or salts of the claimed compounds be excluded from infringement?
A: Not necessarily; the patent explicitly claims salts and derivatives, providing broad coverage unless specifically carved out in licensing agreements or challenged.
Q4: How does the patent landscape influence development of biosimilars or generics?
A: Once the patent expires, developers can produce generics. Prior to expiry, the landscape guides whether licensing or litigation risks are manageable.
Q5: Are there strategies to circumvent this patent in drug development?
A: Yes, designing around the chemical structure, developing novel formulations, or targeting alternative indications are common approaches, subject to patent claim scope and validity.
References
[1] United States Patent and Trademark Office, USPTO Public PAIR database.
[2] Patent scope analysis from Innovence Reports, 2010.
[3] Patent landscape reports from IQVIA, 2020.
[4] Patent Litigation Data, PACER database, 2000–2023.
[5] FDA Orange Book, List of Approved Drugs and patent statuses.
